{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:05Z","timestamp":1791920105780,"version":"4.3.4"},"reference-count":177,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK120531"],"award-info":[{"award-number":["P30 DK120531"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA021978"],"award-info":[{"award-number":["R01 AA021978"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 ES031531"],"award-info":[{"award-number":["R21 ES031531"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.apsb.2021.09.005","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T02:18:26Z","timestamp":1631240306000},"page":"3768-3778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5395-5682","authenticated-orcid":false,"given":"Juliane I.","family":"Beier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-5984","authenticated-orcid":false,"given":"Gavin E.","family":"Arteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.09.005_bib1","series-title":"Origins: fourteen billion years of cosmic evolution","author":"Tyson","year":"2004"},{"key":"10.1016\/j.apsb.2021.09.005_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/siny.2001.0086","article-title":"Inborn errors presenting with liver dysfunction","volume":"7","author":"Clayton","year":"2002","journal-title":"Semin Neonatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41575-019-0156-4","article-title":"Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases","volume":"16","author":"Fabris","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cld.2018.06.001","article-title":"Alagille syndrome","volume":"22","author":"Mitchell","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00383-017-4172-6","article-title":"Update on investigations pertaining to the pathogenesis of biliary atresia","volume":"33","author":"Kilgore","year":"2017","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.apsb.2021.09.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.06.005","article-title":"Biliary atresia: a comprehensive review","volume":"73","author":"Lakshminarayanan","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.apsb.2021.09.005_bib7","first-page":"113","article-title":"Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst-the concept of infantile obstructive cholangiopathy","volume":"6","author":"Landing","year":"1974","journal-title":"Prog Pediatr Surg"},{"key":"10.1016\/j.apsb.2021.09.005_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MPG.0000000000002973","article-title":"Gut microbiome: a potential modifiable risk factor in biliary atresia","volume":"72","author":"Jain","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.apsb.2021.09.005_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0039-1697617","article-title":"The pathogenesis of primary biliary cholangitis: a comprehensive review","volume":"40","author":"Lleo","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1053\/jhep.2001.29760","article-title":"The geographical distribution of primary biliary cirrhosis in a well-defined cohort","volume":"34","author":"Prince","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib13","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.jhepr.2020.100202","article-title":"Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"Dyson","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.apsb.2021.09.005_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/358377a0","article-title":"Molecular mimicry in liver disease","volume":"358","author":"Burroughs","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.09.005_bib15","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid","volume":"174","author":"Amano","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2021.09.005_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0036-1594006","article-title":"Primary biliary cirrhosis and the microbiome","volume":"36","author":"Quigley","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis \u2014 a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0037-1608801","article-title":"The microbiome in primary sclerosing cholangitis: current evidence and potential concepts","volume":"37","author":"Hov","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis","volume":"69","author":"Liwinski","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.09.005_bib21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3748\/wjg.15.1025","article-title":"Influence of genes, sex, age and environment on the onset of autoimmune hepatitis","volume":"15","author":"B\u00e9land","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2021.09.005_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40246-020-00301-4","article-title":"Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response","volume":"15","author":"Higuchi","year":"2021","journal-title":"Hum Genom"},{"key":"10.1016\/j.apsb.2021.09.005_bib23","first-page":"1","article-title":"Epidemiology and treatment of autoimmune hepatitis","volume":"4","author":"Francque","year":"2012","journal-title":"Hepat Med"},{"key":"10.1016\/j.apsb.2021.09.005_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/cld.798","article-title":"Genetic and environmental risk factors for autoimmune hepatitis","volume":"14","author":"Lammert","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.apsb.2021.09.005_bib25","first-page":"248157","article-title":"Xenobiotic exposure and autoimmune hepatitis","volume":"2010","author":"Gilbert","year":"2010","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.apsb.2021.09.005_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bpg.2017.09.013","article-title":"Intestinal microbiome and permeability in patients with autoimmune hepatitis","volume":"31","author":"Cai","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.apsb.2021.09.005_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027940","article-title":"Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.apsb.2021.09.005_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.118.248583","article-title":"Genetic association of single nucleotide polymorphisms with acetaminophen-induced hepatotoxicity","volume":"367","author":"Heruth","year":"2018","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.apsb.2021.09.005_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/hep.23720","article-title":"Pharmacogenetics of drug-induced liver injury","volume":"52","author":"Russmann","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib30","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/hep.31678","article-title":"Acute liver injury with therapeutic doses of acetaminophen: a prospective study","volume":"73","author":"Louvet","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.22798","article-title":"Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen-related hepatotoxicity","volume":"49","author":"Myers","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib32","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.22536","article-title":"Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis","volume":"48","author":"Nguyen","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/toxsci\/kfq034","article-title":"Acute exposure to ozone exacerbates acetaminophen-induced liver injury in mice","volume":"115","author":"Aibo","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.09.005_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tox.2006.10.006","article-title":"Effect of acetaminophen administration to rats chronically exposed to depleted uranium","volume":"229","author":"Gu\u00e9guen","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.apsb.2021.09.005_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/tox.20785","article-title":"Acetaminophen increases the risk of arsenic-mediated development of hepatic damage in rats by enhancing redox-signaling mechanism","volume":"29","author":"Majhi","year":"2014","journal-title":"Environ Toxicol"},{"key":"10.1016\/j.apsb.2021.09.005_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2018.02.024","article-title":"Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice","volume":"69","author":"Gong","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/17425255.2021.1854726","article-title":"Genetic risk factors in the development of idiosyncratic drug-induced liver injury","volume":"17","author":"Stephens","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.apsb.2021.09.005_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2018.09.052","article-title":"Genetic factors that affect spontaneous clearance of hepatitis C or B virus, response to treatment, and disease progression","volume":"156","author":"O\u2019Brien","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.005_bib40","doi-asserted-by":"crossref","first-page":"104663","DOI":"10.1016\/j.meegid.2020.104663","article-title":"Human genetic susceptibility to hepatitis B virus infection","volume":"87","author":"Xu","year":"2021","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.apsb.2021.09.005_bib41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3748\/wjg.v26.i9.883","article-title":"Role of alcohol in pathogenesis of hepatitis B virus infection","volume":"26","author":"Ganesan","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2021.09.005_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tim.2003.12.005","article-title":"Pathophysiology of hepatitis C virus infection and related liver disease","volume":"12","author":"Pawlotsky","year":"2004","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.apsb.2021.09.005_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","article-title":"Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis","volume":"23","author":"Kew","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2021.09.005_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1615\/JEnvironPatholToxicolOncol.2013007166","article-title":"A review of molecular mechanisms in the development of hepatocellular carcinoma by aflatoxin and hepatitis B and C viruses","volume":"32","author":"Moudgil","year":"2013","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"10.1016\/j.apsb.2021.09.005_bib45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s40572-019-00232-w","article-title":"Mechanisms of environmental contributions to fatty liver disease","volume":"6","author":"Wahlang","year":"2019","journal-title":"Curr Env Health Rep"},{"key":"10.1016\/j.apsb.2021.09.005_bib47","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12951-021-00843-2","article-title":"Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors","volume":"19","author":"Sun","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2021.09.005_bib48","doi-asserted-by":"crossref","first-page":"106555","DOI":"10.1016\/j.envint.2021.106555","article-title":"Effects of environmental contaminants in water resources on nonalcoholic fatty liver disease","volume":"154","author":"Zheng","year":"2021","journal-title":"Environ Int"},{"key":"10.1016\/j.apsb.2021.09.005_bib49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2021.09.005_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2020.11.010","article-title":"Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease","volume":"33","author":"Sharpton","year":"2021","journal-title":"Cell Metabol"},{"key":"10.1016\/j.apsb.2021.09.005_bib51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease-the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2021.09.005_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nature Rev Dis primers"},{"key":"10.1016\/j.apsb.2021.09.005_bib53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.09.005_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0192623312468517","article-title":"Toxicant-associated steatohepatitis","volume":"41","author":"Wahlang","year":"2013","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.apsb.2021.09.005_bib55","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.toxrep.2021.03.010","article-title":"Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis","volume":"8","author":"Wahlang","year":"2021","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.apsb.2021.09.005_bib56","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s00125-016-3940-5","article-title":"Hepatic glucose and lipid metabolism","volume":"59","author":"Jones","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2021.09.005_bib57","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1001\/archinte.1983.00350120085018","article-title":"Normal liver function. A basis for understanding hepatic disease","volume":"143","author":"Corless","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.apsb.2021.09.005_bib58","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib59","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000374089","article-title":"Drug-induced liver injury is a major risk for new drugs","volume":"33","author":"Seeff","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0034-1375962","article-title":"Drug-induced liver injury and drug development: industry perspective","volume":"34","author":"Regev","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib61","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1089-3261(05)70027-1","article-title":"Occupational hepatotoxicity","volume":"2","author":"Tolman","year":"1998","journal-title":"Clin Liv Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib62","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: a matter of life and death","volume":"15","author":"Schwabe","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular senescence: aging, cancer, and injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2021.09.005_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0037-1601351","article-title":"Update on the mechanisms of liver regeneration","volume":"37","author":"Preziosi","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib65","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrm1489","article-title":"Liver regeneration: from myth to mechanism","volume":"5","author":"Taub","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2021.09.005_bib66","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1053\/j.gastro.2006.01.038","article-title":"Toll-like receptor signaling in the liver","volume":"130","author":"Schwabe","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.005_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib68","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jhbp.245","article-title":"Recent advancement of molecular mechanisms of liver fibrosis","volume":"22","author":"Seki","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.apsb.2021.09.005_bib69","doi-asserted-by":"crossref","first-page":"100115","DOI":"10.1016\/j.jhepr.2020.100115","article-title":"The liver matrisome\u2014looking beyond collagens","volume":"2","author":"Arteel","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.apsb.2021.09.005_bib70","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.clinre.2018.03.007","article-title":"Wilson's disease: a 2017 update","volume":"42","author":"Poujois","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.apsb.2021.09.005_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijerph5010004","article-title":"Gene-environment interactions in the development of complex disease phenotypes","volume":"5","author":"Ramos","year":"2008","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.apsb.2021.09.005_bib72","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.pcl.2017.02.003","article-title":"Pediatric liver transplantation","volume":"64","author":"Rawal","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.apsb.2021.09.005_bib73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajmg.a.37429","article-title":"Discordant clinical phenotype in monozygotic twins with Alagille syndrome: possible influence of non-genetic factors","volume":"170a","author":"Izumi","year":"2016","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.apsb.2021.09.005_bib74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ajmg.10610","article-title":"Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance","volume":"112","author":"Kamath","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.apsb.2021.09.005_bib75","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1183\/09031936.05.00021605","article-title":"\u03b11-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants","volume":"26","author":"Senn","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.apsb.2021.09.005_bib76","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/gutjnl-2018-316228","article-title":"Heterozygous carriage of the alpha1-antitrypsin Pi\u2217Z variant increases the risk to develop liver cirrhosis","volume":"68","author":"Strnad","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.09.005_bib77","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/JLB.4RU0620-245R","article-title":"Macrophage dysfunction in cystic fibrosis: nature or nurture?.","volume":"109","author":"Turton","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2021.09.005_bib78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0065-3101(23)00034-8","article-title":"Gene modifiers in pediatrics: application to cystic fibrosis","volume":"51","author":"Sontag","year":"2004","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.apsb.2021.09.005_bib79","doi-asserted-by":"crossref","first-page":"13529","DOI":"10.3390\/ijms150813529","article-title":"Cystic fibrosis related liver disease\u2014another black box in hepatology","volume":"15","author":"Staufer","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.09.005_bib80","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.envint.2019.05.056","article-title":"Bioaccumulation in the gut and liver causes gut barrier dysfunction and hepatic metabolism disorder in mice after exposure to low doses of OBS","volume":"129","author":"Wang","year":"2019","journal-title":"Environ Int"},{"key":"10.1016\/j.apsb.2021.09.005_bib81","doi-asserted-by":"crossref","first-page":"124639","DOI":"10.1016\/j.jhazmat.2020.124639","article-title":"Effects of chlorothalonil, prochloraz and the combination on intestinal barrier function and glucolipid metabolism in the liver of mice","volume":"410","author":"Wang","year":"2021","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.apsb.2021.09.005_bib82","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41467-020-20461-0","article-title":"Lysosomal SLC46A3 modulates hepatic cytosolic copper homeostasis","volume":"12","author":"Kim","year":"2021","journal-title":"Nature Commun"},{"key":"10.1016\/j.apsb.2021.09.005_bib83","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00044-020-02581-w","article-title":"Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity","volume":"29","author":"Jin","year":"2020","journal-title":"Med Chem Res"},{"key":"10.1016\/j.apsb.2021.09.005_bib84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1751-0813.1990.tb07385.x","article-title":"Congenital biliary atresia and jaundice in lambs and calves","volume":"67","author":"Harper","year":"1990","journal-title":"Aust Vet J"},{"key":"10.1016\/j.apsb.2021.09.005_bib85","doi-asserted-by":"crossref","first-page":"286ra67","DOI":"10.1126\/scitranslmed.aaa1652","article-title":"Identification of a plant isoflavonoid that causes biliary atresia","volume":"7","author":"Lorent","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2021.09.005_bib86","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.28599","article-title":"The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17","volume":"64","author":"Waisbourd-Zinman","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib87","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2468-1253(19)30343-7","article-title":"Current and potential treatments for primary biliary cholangitis","volume":"5","author":"Shah","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib88","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.005_bib89","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.apsb.2021.09.005_bib91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1535370217748893","article-title":"Environmental basis of primary biliary cholangitis","volume":"243","author":"Tanaka","year":"2018","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.apsb.2021.09.005_bib92","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hep.20028","article-title":"Unusual suspects in primary biliary cirrhosis","volume":"39","author":"Vergani","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib94","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.09.005_bib95","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365520600787994","article-title":"Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden","volume":"42","author":"Bergquist","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.apsb.2021.09.005_bib96","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib97","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.51.1.120","article-title":"High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6","volume":"51","author":"Xu","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.09.005_bib98","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.005_bib99","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jhep.2010.12.041","article-title":"Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis","volume":"55","author":"Lucena","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib101","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1289\/ehp.11782","article-title":"Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans","volume":"117","author":"Cooper","year":"2009","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.apsb.2021.09.005_bib102","doi-asserted-by":"crossref","first-page":"s104","DOI":"10.7861\/clinmedicine.16-6-s104","article-title":"Drug-induced liver injury","volume":"16","author":"Katarey","year":"2016","journal-title":"Clinical Med (Lond)"},{"key":"10.1016\/j.apsb.2021.09.005_bib103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury\u2014types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.09.005_bib104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0039-1679919","article-title":"Acetaminophen hepatotoxicity","volume":"39","author":"Ramachandran","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nature Rev Dis Primers"},{"key":"10.1016\/j.apsb.2021.09.005_bib106","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib107","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cgh.2017.12.036","article-title":"Heavy consumption of alcohol is not associated with worse outcomes in patients with idiosyncratic drug-induced liver injury compared to non-drinkers","volume":"16","author":"Dakhoul","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib108","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/taap.1995.1115","article-title":"Relative potencies of induction of hepatic drug-metabolizing enzyme genes by individual PCB congeners","volume":"132","author":"Dragnev","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2021.09.005_bib109","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41590-020-0802-6","article-title":"Environmental pollutants and the immune response","volume":"21","author":"Suzuki","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2021.09.005_bib110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/17425255.2012.637918","article-title":"Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics","volume":"8","author":"Fardel","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.apsb.2021.09.005_bib111","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jcph.23","article-title":"Drug-induced liver injury: the role of drug metabolism and transport","volume":"53","author":"Corsini","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2021.09.005_bib112","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40264-018-0743-2","article-title":"Drug-induced liver injury: highlights of the recent literature","volume":"42","author":"Real","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.apsb.2021.09.005_bib113","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/21505594.2021.1910442","article-title":"Pathogenicity and virulence of hepatitis A virus","volume":"12","author":"Pint\u00f3","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.apsb.2021.09.005_bib114","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gtc.2020.01.011","article-title":"Hepatitis E: epidemiology, clinical course, prevention, and treatment","volume":"49","author":"Goel","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.apsb.2021.09.005_bib115","doi-asserted-by":"crossref","first-page":"20160274","DOI":"10.1098\/rstb.2016.0274","article-title":"Viral hepatitis and liver cancer","volume":"372","author":"Ringelhan","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.apsb.2021.09.005_bib116","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2021.09.005_bib117","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.apsb.2021.09.005_bib118","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000447279","article-title":"Alcohol and obesity: a dangerous association for fatty liver disease","volume":"34 Suppl 1","author":"Mahli","year":"2016","journal-title":"Dig Dis"},{"key":"10.1016\/j.apsb.2021.09.005_bib119","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.23321","article-title":"Toxicant-associated steatohepatitis in vinyl chloride workers","volume":"51","author":"Cave","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib120","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.005_bib121","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib122","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib123","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hep4.1151","article-title":"Vinyl chloride dysregulates metabolic homeostasis and enhances diet-induced liver injury in mice","volume":"2","author":"Lang","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.apsb.2021.09.005_bib124","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1515\/hsz-2017-0324","article-title":"Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk","volume":"399","author":"Lang","year":"2018","journal-title":"Biol Chem"},{"key":"10.1016\/j.apsb.2021.09.005_bib125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfw018","article-title":"Tipping the balance: hepatotoxicity and the 4 apical key events of hepatic steatosis","volume":"150","author":"Angrish","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.09.005_bib126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.apsb.2021.09.005_bib127","doi-asserted-by":"crossref","first-page":"112256","DOI":"10.1016\/j.ecoenv.2021.112256","article-title":"Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants","volume":"217","author":"Zhang","year":"2021","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.apsb.2021.09.005_bib128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jcmgh.2015.05.006","article-title":"Alcoholic, nonalcoholic, and toxicant-associated steatohepatitis: mechanistic similarities and differences","volume":"1","author":"Joshi-Barve","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib129","first-page":"3","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-Butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide)","volume":"97","year":"2008","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.apsb.2021.09.005_bib130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.1974.03240010032024","article-title":"Liver damage and angiosarcoma in vinyl chloride workers. a systematic detection program","volume":"230","author":"Makk","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2021.09.005_bib131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/hep.1840040310","article-title":"Early hepatic histologic alterations among chemical (vinyl monomer) workers","volume":"4","author":"Tamburro","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib132","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1974.03230390029019","article-title":"Angiosarcoma of the liver following vinyl chloride exposure","volume":"229","author":"Block","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2021.09.005_bib133","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/0192623314549960","article-title":"Identification of environmental chemicals associated with the development of toxicant-associated fatty liver disease in rodents","volume":"43","author":"Al-Eryani","year":"2015","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.apsb.2021.09.005_bib134","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40572-019-00231-x","article-title":"Understanding environmental contaminants' direct effects on non-alcoholic fatty liver disease progression","volume":"6","author":"Armstrong","year":"2019","journal-title":"Current Environ Health Rep"},{"key":"10.1016\/j.apsb.2021.09.005_bib135","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.09.005_bib136","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival","volume":"109","author":"Jemal","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.apsb.2021.09.005_bib137","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008469-199808000-00007","article-title":"Liver cirrhosis and the risk of primary liver cancer","volume":"7","author":"La Vecchia","year":"1998","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.apsb.2021.09.005_bib138","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.005_bib139","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2012.11.041","article-title":"Polychlorinated biphenyls (PCBs) as initiating agents in hepatocellular carcinoma","volume":"334","author":"Ludewig","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2021.09.005_bib140","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2009.09.012","article-title":"Vinyl chloride and the liver","volume":"51","author":"Sherman","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib141","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/toxsci\/kfn120","article-title":"Liver is a target of arsenic carcinogenesis","volume":"105","author":"Liu","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.09.005_bib142","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.scitotenv.2015.10.003","article-title":"Association of environmental benzo[a]pyrene exposure and DNA methylation alterations in hepatocellular carcinoma: a Chinese case-control study","volume":"541","author":"Tian","year":"2016","journal-title":"Sci Tot Environ"},{"key":"10.1016\/j.apsb.2021.09.005_bib143","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajpath.2018.12.006","article-title":"Liver regeneration after acetaminophen hepatotoxicity: mechanisms and therapeutic opportunities","volume":"189","author":"Bhushan","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2021.09.005_bib144","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00204-003-0499-y","article-title":"Time-course of cadmium-induced acute hepatotoxicity in the rat liver: the role of apoptosis","volume":"77","author":"Tzirogiannis","year":"2003","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2021.09.005_bib145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2184.1995.tb00084.x","article-title":"Inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on rat hepatocyte proliferation induced by 2\/3 partial hepatectomy","volume":"28","author":"Bauman","year":"1995","journal-title":"Cell Prolif"},{"key":"10.1016\/j.apsb.2021.09.005_bib146","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2016.05.001","article-title":"The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction","volume":"304","author":"Beggs","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2021.09.005_bib147","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.fct.2013.01.035","article-title":"Combined effects of organochlorine pesticides heptachlor and hexachlorobenzene on the promotion stage of hepatocarcinogenesis in rats","volume":"55","author":"Abdo","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.apsb.2021.09.005_bib148","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/90.22.1702","article-title":"Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha","volume":"90","author":"Gonzalez","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.apsb.2021.09.005_bib149","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.005_bib150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MPG.0b013e3181b47b49","article-title":"Reloading against rare liver diseases","volume":"50","author":"Sokol","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.apsb.2021.09.005_bib151","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30418","article-title":"Improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic steatohepatitis: results from the Nonalcoholic Steatohepatitis Clinical Research Network Treatment trials","volume":"70","author":"Brunt","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib152","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCRESAHA.117.310967","article-title":"Biomedical Informatics on the cloud: a treasure hunt for advancing cardiovascular medicine","volume":"122","author":"Ping","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2021.09.005_bib153","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-publhealth-040617-014208","article-title":"Big data in public health: terminology, machine learning, and privacy","volume":"39","author":"Mooney","year":"2018","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.apsb.2021.09.005_bib154","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2013liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.119.4.633","article-title":"Influence of neomycin and ingested endotoxin in the pathogenesis of choline deficiency cirrhosis in the adult rat","volume":"119","author":"Broitman","year":"1964","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2021.09.005_bib156","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.09.005_bib157","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fcimb.2017.00396","article-title":"Gut dysbiosis in animals due to environmental chemical exposures","volume":"7","author":"Rosenfeld","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2021.09.005_bib158","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1111\/risa.13316","article-title":"Do interactions between environmental chemicals and the human microbiome need to be considered in risk assessments?.","volume":"39","author":"Rodricks","year":"2019","journal-title":"Risk Anal"},{"key":"10.1016\/j.apsb.2021.09.005_bib159","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.cell.2021.01.043","article-title":"Hallmarks of environmental insults","volume":"184","author":"Peters","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.09.005_bib160","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.22223","article-title":"Racial disparity in liver disease: biological, cultural, or socioeconomic factors","volume":"47","author":"Nguyen","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib161","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1572-0241.2008.02022.x","article-title":"Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999\u20132004","volume":"103","author":"Flores","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.apsb.2021.09.005_bib162","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2021.09.005_bib163","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.005_bib164","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1001\/jama.2016.13645","article-title":"US county-level trends in mortality rates for major causes of death, 1980\u20132014","volume":"316","author":"Dwyer-Lindgren","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2021.09.005_bib165","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2020.11.016","article-title":"County differences in liver mortality in the United States: impact of sociodemographics, disease risk factors, and access to care","volume":"160","author":"Goldberg","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.005_bib166","article-title":"Environmental justice in the American public health context: trends in the scientific literature at the intersection between health, environment, and social status","author":"Smith","year":"2021","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.apsb.2021.09.005_bib167","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s40572-020-00263-8","article-title":"Chemical exposures, health, and environmental justice in communities living on the fenceline of industry","volume":"7","author":"Johnston","year":"2020","journal-title":"Curr Environ Health Rep"},{"key":"10.1016\/j.apsb.2021.09.005_bib168","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1377\/hlthaff.2010.1225","article-title":"From endocrine disruptors to nanomaterials: advancing our understanding of environmental health to protect public health","volume":"30","author":"Birnbaum","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.apsb.2021.09.005_bib169","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1158\/1055-9965.EPI-05-0456","article-title":"Complementing the genome with an \"exposome\": the outstanding challenge of environmental exposure measurement in molecular epidemiology","volume":"14","author":"Wild","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.apsb.2021.09.005_bib170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxrep.2015.11.009","article-title":"Sequencing the exposome: a call to action","volume":"3","author":"Jones","year":"2016","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.apsb.2021.09.005_bib171","doi-asserted-by":"crossref","first-page":"110041","DOI":"10.1016\/j.envres.2020.110041","article-title":"Multi-omics analysis reveals that co-exposure to phthalates and metals disturbs urea cycle and choline metabolism","volume":"192","author":"Papaioannou","year":"2021","journal-title":"Environ Res"},{"key":"10.1016\/j.apsb.2021.09.005_bib172","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/metabo10110454","article-title":"Metabolic signatures of the exposome-quantifying the impact of exposure to environmental chemicals on human health","volume":"10","author":"Ore\u0161i\u010d","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.apsb.2021.09.005_bib173","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3389\/fimmu.2018.02727","article-title":"Leveraging multilayered \"omics\" data for atopic dermatitis: a road map to precision medicine","volume":"9","author":"Ghosh","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2021.09.005_bib174","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/hep.31028","article-title":"Studying the Exposome to understand the environmental determinants of complex liver diseases","volume":"71","author":"Cheung","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.09.005_bib175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000514884","article-title":"Environmental exposure during pregnancy: influence on prenatal development and early life: a comprehensive review","volume":"48","author":"G\u00f3mez-Roig","year":"2021","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.apsb.2021.09.005_bib176","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/en.2015-1394","article-title":"Developmental origins of health and disease: integrating environmental influences","volume":"156","author":"Heindel","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2021.09.005_bib177","doi-asserted-by":"crossref","first-page":"129735","DOI":"10.1016\/j.chemosphere.2021.129735","article-title":"Molecular mechanism of heavy metals (lead, chromium, arsenic, mercury, nickel and cadmium)-induced hepatotoxicity\u2014a review","volume":"271","author":"Renu","year":"2021","journal-title":"Chemosphere"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:50:30Z","timestamp":1761929430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521003476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":177,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2211383521003476"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.09.005","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}